Cancer Research

The traditional landscape of oncological drug development is currently undergoing a massive transformation as Oregon Health & Science University launches an ambitious $9.2 million initiative to redefine the accuracy of preclinical testing. By establishing the Knight Cancer Precision Biofabrication

While chimeric antigen receptor T-cell therapy has already revolutionized the treatment of hematologic malignancies, the biological fortress surrounding solid tumors continues to pose a formidable challenge for researchers and clinicians alike. Unlike the relatively accessible nature of blood

The pursuit of a reliable therapeutic strategy for metastatic pancreatic ductal adenocarcinoma has remained one of the most frustrating and stagnant chapters in modern oncology for decades. This specific malignancy is notorious for its silent progression, aggressive biological behavior, and a

The persistent struggle against lung cancer has long relied on radiation therapy to dismantle the genetic integrity of malignant cells, yet many aggressive tumors possess an uncanny ability to withstand these high-energy assaults. Recent breakthroughs from The University of Texas MD Anderson Cancer

The rapid transition of CRISPR-Cas systems from revolutionary laboratory experiments to sophisticated clinical interventions has necessitated a comprehensive overhaul of traditional safety protocols to protect patient health in the coming years. As genome editing moves beyond the initial

The landscape of computational oncology is currently undergoing a radical transformation as artificial intelligence begins to master the complex chemical language required to neutralize aggressive tumors. This technological leap is particularly evident in the development of selective inhibitors for